Farmacy

Jul 8 2018

OHRP stock quote – Ohr Pharmaceutical, Inc, pharmaceutical classes.#Pharmaceutical #classes

Ohr Pharmaceutical, Inc. Common Stock Quote & Summary Data

Stock Details
COMPANY NEWS
FUNDAMENTALS

Edit Symbol List

Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.

Don’t know the stock symbol? Use the Symbol Lookup tool.

Alphabetize the sort order of my symbols

Symbol Lookup

Investing just got easier

Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.

“Best Ask” is the lowest price currently being asked for a block of stock.

“Today’s Low” The lowest sales price the stock has fallen to during the regular trading hours, the intra-day low.

“52 Week Low” is the lowest sales price the stock has fallen to during the regular trading hours during the most recent 52 week period.

Prices during the When Issued trading period are used in the 52 week high/low calculation.

Intraday Chart

Company Description (as filed with the SEC)

Ohr Pharmaceutical, Inc. (“we,” “us,” “our,” “Ohr,” or the “Company”) is a pharmaceutical company focused on the development of novel therapeutics and delivery technologies for the treatment of ocular disease. Our development pipeline consists of several programs and indications at various stages of development. Our lead clinical asset, topical Squalamine (also known as squalamine lactate ophthalmic solution, 0.2%, or OHR-102), is a novel therapeutic product which could provide a non-invasive therapy to improve vision outcomes beyond that achieved with current standard of care, without requiring multiple injections per office visit. We are conducting a Phase 3 registration program evaluating Squalamine in combination with Lucentis® injections for the treatment of wet-AMD. . More .

Risk Grade

Where does OHRP fit in the risk graph?

Pharmaceutical classes





Written by admin


Leave a Reply

Your email address will not be published. Required fields are marked *